Superantigens trigger polyclonal activation of T lymphocytes with cytokine release that eventually may lead to lethal cytokine syndrome (toxic shock). In contrast, bacterial components that are recognized by Toll-like receptors (e.g. LPS or CpG DNA) primarily target macrophages and dendritic cells. We have analyzed whether superantigens and TLR ligands interact with each other. We found that superantigens synergize with LPS in an IFN-g-dependent pathway. More important, we found compelling evidence that superantigens prime the innate immune cell system to a subsequent challenge with endotoxin. This sensitization was critically dependent on T-cell derived IFN-g. When we analyzed the underlying molecular mechanisms, we additionally found that TLR stimulation enhanced IFN-g-mediated cellular responses. Moreover, TLR ligands induced proteins of the SOCS family thus shutting off IFN-g-mediated cellular activation. Since IFN-g is synthesized by T cells after superantigen triggering, these results show that superantigen and TLR pathways are interconnected and regulate each other. They further show that the outcome of this interaction may include activation as well as down-regulation of the respective response pattern.
INTRODUCTION
Pathogen-associated molecular pattern (PAMP) triggers innate immune cells to respond to infectious danger. PAMPs comprise structural bacterial components such as lipopolysaccharides (LPS), peptidoglycan (PepG), lipoteichoic acid (LTA) and bacterial CpG DNA. These PAMPs are recognized dependent on Toll-like receptors (TLRs). 1 Different PAMPs are recognized by distinct TLRs. During bacterial encounter, multiple TLR ligands activate a set of different TLRs leading to a variety of interactions. Thus, TLR ligands induce phenomena such as synergism, induction of tolerance, and cross-tolerance. 2, 3 However, immunologically relevant bacterial products are not confined to TLR ligands. In addition, bacterial exotoxins, such as pore-forming toxins or enterotoxins, play an important role during innate immune responses.
Staphylococcal enterotoxins were the first to be recognized as superantigens. Superantigens activate a large fraction of peripheral T cells due to their ability to bridge antigen-presenting cells (APCs) to T cells bearing T-cell receptors (TCRs) with distinct Vb-gene encoded portions. 4 Thus, superantigens like the staphylococcal enterotoxin B (SEB) activate all T cells expressing a defined set of Vb-TCR, irrespective of their actual antigen specificity. 5 As a consequence, up to 25% of the total peripheral T-cell pool becomes activated. Cytokines triggered by superantigens are T-cell derived and may eventually induce a lethal cytokine syndrome. 6 Superantigens, therefore, can contribute to septic complications during infections which is underlined by the toxic shock syndrome (TSS) that is caused by toxin-producing staphylococci.
We were interested in whether the TLR-dependent recognition pathway of PAMP may be interconnected with exotoxin-triggered immune activation by superantigens. This study investigates if both systems are interconnected and enhance each other in terms of synergism and sensitization. In addition, the molecular mechanisms that underlie these effects have been studied.
MATERIALS AND METHODS

Mice
BALB/c female mice were obtained from Bomholtgard, Denmark or Charles River, Marktbreit, Germany. Mice were kept under specific pathogen-free (SPF) conditions and used at an age of 10-12 weeks.
Reagents and cell lines
LPS (Escherichia coli) was from Sigma (Deisenhofen, Germany). Staphylococcal enterotoxin B (SEB) was purchased from Toxin Technology (Sarasota, FL, USA). If not otherwise stated, mice were injected intraperitoneally with the reagents as indicated in the respective experiment. For survival studies, mice were monitored at intervals of 4-6 h. Hybridoma HB-170 (American Type Culture Collection, ATCC) producing anti-IFN-g monoclonal antibodies (mAbs) were grown in a bioreactor. Cell-free supernatant was harvested and Ig concentrations were determined by ELISA. For the in vivo experiments, 50 mg mAb/mouse were injected intraperitoneally.
Cytokine ELISA
The following antibodies were used for the cytokine ELISA (TNF-a): capture mAb (clone MP6-T22), detector antibody (polyclonal rabbit anti-TNF). mAbs were purchased from PharMingen (Hamburg, Germany). ELISA was performed as recommended by the manufacturer. Standard recombinant cytokine preparations were diluted in PBS containing normal mouse serum. A standard curve was obtained using 4-parameter logistic fit function and from that the samples' values were calculated.
RESULTS AND DISCUSSION
We have previously shown that superantigen triggers T cells to produce a large amount of pro-inflammatory cytokines which can induce a lethal cytokine syndrome. 6 Superantigen-mediated lethal shock was dependent on T-cell derived TNF and thus resembled lethal shock induced by endotoxin. This prompted us to test whether both limbs of induction of pro-inflammatory cytokines would interact with each other. We reported that superantigen and endotoxin when given simultaneously acted synergistically. Lethal doses were reduced for both inducers and cytokine levels enhanced. Synergism was mediated by T-cell derived IFN-g since blockade with anti-IFN-g mAb or inhibition of T cells with cyclosporin A completely abolished synergism. 7 We also recognized that pretreatment with superantigens was able to prime for the lethal effect of endotoxin. A representative experiment is shown in Figure 1 . While injection of moderate doses of superantigen was not able to trigger a lethal cytokine syndrome, mice gained an increased sensitivity to endotoxin. At 4 h after administration of superantigen SEB, the injection of an otherwise non-lethal dose of LPS induced very high serum levels of TNF-a which ranged from 70-73.6 ng/ml (compared to 1.75-2.38 ng/ml without pre-injection of SEB). This, in turn, induced a lethal cytokine syndrome. Superantigens sensitized mice for a limited time period. In terms of induction of a lethal cytokine syndrome, this time window was 4-24 h after SEB administration. In parallel, sensitization for TNF-a production was observed within 4-16 h after superantigen administration. After 24 h, the sensitivity to endotoxin decreased to only slightly elevated values (Fig. 1) . However, priming with SEB 48 h prior to LPS challenge still showed increased cytokine production, but failed to induce lethality anymore.
When we analyzed the mechanisms of superantigenmediated sensitization, we found that cyclosporin A protected mice from lethality underlining that T cells are the central mediators of sensitization (data not shown). In addition, in vivo blockade with anti-IFN-g mAb prevented sensitization (summarized in Table 1 ). Hence superantigen-mediated T-cell activation which is followed by extensive cytokine secretion sensitizes mice for the lethal effects of endotoxin. It has been reported that IL-12 and IL-18 contribute to the regulation of IFNg secretion. However, superantigen-mediated induction of sensitivity to LPS seems not to be dependent on these cytokines. First, blockade of IL-12 by antibodies during the initial phase failed to prevent sensitization (data not shown). Second, in IL-18 -/mice, superantigen-mediated sensitization was still operative. 8 Sensitization could further be characterized by changes in the APC compartment. Upon superantigen stimulation, peritoneal exudate cells (PECs) expressed higher amounts of CD14 (data not shown). In addition, IL-2Rb and IL-2Rg chains were increased while CD40 and IL-2Ra chain expression remained unchanged. These alterations were correlated in duration with the sensitivity window for LPS. Since TLR expression seems to be increased by stimulation with IFN-g, we also anticipate up-regulation of TLR upon superantigen triggering. 9 We also analyzed the molecular interactions of superantigen-induced IFN-g and TLR triggered signals. Using STAT-1-reporter constructs, we found that TLR triggering was able to enhance activation by IFN-g (manuscript submitted). Similar results have been reported for cooperative effects of LPS on IFN-g signaling, and LPSinduced phosphorylation of serine 727 within STAT-1 has been shown to participate in this enhancement. 10 Thus, not only IFN-g enhances responses triggered by TLR ligands, but the opposite way is also operative.
Suppressors of cytokine signaling (SOCS) have been described as negative feedback inhibitors that down-regulate JAK-STAT signaling. 11 Initially, it was thought that SOCS proteins are induced by STAT-dependent signal pathways only. However, we and others have shown that SOCS proteins can be induced by a variety of TLR ligands in addition. [12] [13] [14] Therefore, superantigen-induced and IFN-g-dependent signal pathways are interconnected with TLR-dependent pathways at multiple levels. It is obvious that the overall response to microbial challenge depends critically on both pathways.
CONCLUSIONS
Innate immune responses are a result of complex signal integration processes that are dependent on the temporal and spatial patterns of immune-activating ligands. The multiple interactions and interconnectivity between PAMPs and other bacterial products are complex and occur at multiple levels. Hence, therapeutic interventions aiming to interfere with a single entity do not consider these connections and thus may fail. 
